These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10849185)

  • 1. Aminoglycoside dosing in diabetes.
    Axworthy S; Gardner D
    J Clin Pharm Ther; 2000 Apr; 25(2):81-4. PubMed ID: 10849185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-interval dosing of aminoglycosides.
    Blam ME; Hammer GS
    Mt Sinai J Med; 1997 Nov; 64(6):386-91. PubMed ID: 9364833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.
    Nestaas E; Bangstad HJ; Sandvik L; Wathne KO
    Arch Dis Child Fetal Neonatal Ed; 2005 Jul; 90(4):F294-300. PubMed ID: 15857879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    J Antimicrob Chemother; 1997 Jun; 39(6):677-86. PubMed ID: 9222035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.
    Bailey TC; Little JR; Littenberg B; Reichley RM; Dunagan WC
    Clin Infect Dis; 1997 May; 24(5):786-95. PubMed ID: 9142771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients.
    Mueller EW; Boucher BA
    Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis.
    Hatala R; Dinh T; Cook DJ
    Ann Intern Med; 1996 Apr; 124(8):717-25. PubMed ID: 8633831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Daily single-dose aminoglycoside administration. Therapeutic and economic benefits].
    Knudsen LM; Frimodt-Møller N; Hansen MT; Hippe E
    Ugeskr Laeger; 1993 May; 155(19):1436-41. PubMed ID: 8316969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing.
    Kim MJ; Bertino JS; Erb TA; Jenkins PL; Nafziger AN
    J Clin Pharmacol; 2004 Jul; 44(7):696-707. PubMed ID: 15199074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA; Nagel JL
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily dosing of aminoglycoside antibiotics.
    Fisman DN; Kaye KM
    Infect Dis Clin North Am; 2000 Jun; 14(2):475-87. PubMed ID: 10829267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single or multiple daily doses of aminoglycosides: a meta-analysis.
    Barza M; Ioannidis JP; Cappelleri JC; Lau J
    BMJ; 1996 Feb; 312(7027):338-45. PubMed ID: 8611830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Tan KH
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002009. PubMed ID: 16855982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J; Tight R; Rajkumar V; Hawa Z
    Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once daily versus multiple daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Tan K; Bunn H
    Cochrane Database Syst Rev; 2000; (4):CD002009. PubMed ID: 11034740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of aminoglycosides once-a-day: experimental and clinical data.
    Tulkens PM
    Scand J Infect Dis Suppl; 1990; 74():249-57. PubMed ID: 2097713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single daily dose therapy with aminoglycosides.
    Nordström L; Lerner SA
    J Hosp Infect; 1991 Jun; 18 Suppl A():117-29. PubMed ID: 1679774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic evaluation of once-daily aminoglycoside treatment.
    Periti P
    J Chemother; 1995 Aug; 7(4):380-94. PubMed ID: 8568549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended interval aminoglycoside dosing: from concept to clinic.
    Maglio D; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2002 Apr; 19(4):341-8. PubMed ID: 11978505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.